| Literature DB >> 26471729 |
Qian Hao1, Shi Jiao1, Zhubing Shi1, Chuanchuan Li1, Xia Meng1, Zhen Zhang1, Yanyan Wang1, Xiaomin Song1, Wenjia Wang1, Rongguang Zhang1, Yun Zhao1, Catherine C L Wong2, Zhaocai Zhou3.
Abstract
RIG-I is a well-studied sensor of viral RNA that plays a key role in innate immunity. p97 regulates a variety of cellular events such as protein quality control, membrane reassembly, DNA repair, and the cell cycle. Here, we report a new role for p97 with Npl4-Ufd1 as its cofactor in reducing antiviral innate immune responses by facilitating proteasomal degradation of RIG-I. The p97 complex is able to directly bind both non-ubiquitinated RIG-I and the E3 ligase RNF125, promoting K48-linked ubiquitination of RIG-I at residue K181. Viral infection significantly strengthens the interaction between RIG-I and the p97 complex by a conformational change of RIG-I that exposes the CARDs and through K63-linked ubiquitination of these CARDs. Disruption of the p97 complex enhances RIG-I antiviral signaling. Consistently, administration of compounds targeting p97 ATPase activity was shown to inhibit viral replication and protect mice from vesicular stomatitis virus (VSV) infection. Overall, our study uncovered a previously unrecognized role for the p97 complex in protein ubiquitination and revealed the p97 complex as a potential drug target in antiviral therapy.Entities:
Keywords: RIG‐I; antiviral signaling; mechanism; p97‐Npl4; ubiquitination
Mesh:
Substances:
Year: 2015 PMID: 26471729 PMCID: PMC4687688 DOI: 10.15252/embj.201591888
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598